Latest News – AM Biotech

ExoGiov® Innovation: AM Biotech Accelerates European Expansion

admin — Wed, 18 Jun 2025 09:50:00 +0000

ExoGiov®, a cosmetic raw material developed by AM Biotech, is registered under the international INCI name: "Chicken Embryonic Mesenchymal Cell-Derived Extracellular Vesicles."

Source

AM Biotech Wins Prestigious National Innovation Award, Pioneering Bio-Pulsed Exosome Research

ambiotechadmin — Fri, 03 Jan 2025 08:09:03 +0000

AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.

Source

AM Biotech Unveils Patented Bio-Pulsed Technology at Industry Forum

ambiotechadmin — Mon, 16 Dec 2024 09:01:45 +0000

AM Bio Tech's "Patented Bio-Pulsed Technology Forum" held on December 15, 2024, successfully concluded. The event delved deep into the groundbreaking innovation behind Patented Bio-Pulsed Technology, shedding light on its mechanisms and providing compelling evidence of its effectiveness in skin rejuvenation and hair restoration. The forum attracted a distinguished audience of medical aesthetics, beauty, and hair care professionals who were eager to learn more about this cutting-edge technology and its potential applications. Attendees gained valuable insights into the technology's clinical efficacy, making it a compelling choice for their product offerings.

Source

AM Biotech joins forces with PITDC to advance biotech innovation and expand into the trillion-dollar pharmaceutical market.

ambiotechadmin — Tue, 10 Sep 2024 02:03:14 +0000

Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a “Pharmaceutical Project Cooperation Development Agreement.” This collaboration marks the official launch of several biotech and pharmaceutical development projects, as AM BioTech ventures into the trillion-dollar pharmaceutical market.

Source

AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global

ambiotechadmin — Thu, 09 May 2024 02:37:43 +0000

Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer of patented technology Bio-Pulsed Exosomes (Extracellular Vesicles), it is a Global Cross-Generation Innovative Cosmetic Ingredient recognized and favored by the international market in Europe and America.

Source

According to the EUROPE DIRECT CONTACT CENTRE Consultation Response: ExoGiov Comes from SPF Eggs and Does Not Fall under the Categories Mentioned in ANNEX II/419

ambiotechadmin — Thu, 21 Mar 2024 03:05:20 +0000

All cosmetics related to animal sources and derived ingredients will be labeled ANNEX II/419. However, this is only for reference and not as a basis for restriction/prohibition.

Source

AM Biotech’s Unique Bio-pulsed Exosome, Backed by Patents, Shows Bright Prospects in the Global Market

ambiotechadmin — Fri, 19 Jan 2024 05:58:51 +0000

Chairman of AM Biotech, shared the strategic layout of the “bio-pulse induced exosome Technology Platform.” With the continuous acquisition of international patents, AM Biotech’s Technology is well-positioned for international market expansion and has already engaged in discussions for collaborations in overseas markets.

Source

Chairman of AM Biotech Went to The 49th Annual Meeting of Taiwanese Dermatological Association (TDA) to Give A Special Lecture

ambiotechadmin — Sat, 30 Dec 2023 07:00:14 +0000

Special Lecture at the 2024 Taiwan Dermatology Annual Conference. Discussing the efficiency and mechanism of bio-pulsed exosomes in beauty and hair growth from the perspective of miRNA and genes.

Source

Bio-Pulsed Exosome with innovative patented technology from AM Biotech to restore health and beauty

ambiotechadmin — Wed, 29 Nov 2023 02:10:00 +0000

Ascension Medical Biotechnology company(AM Biotech) from Taiwan focusing on the research and development of induced and specific functional exosome. At the seminar on innovative technologies and applications of bio-pulsed exosome on November 19, With “innovative technology”, As the theme, Dr. Shieh, chairman of AM biotech and inventor of bio-pulsed exosome technology, invited exosome research experts, including Professor Shen Tanglong, director of Biotechnology Center of Taiwan University, who just won the “World Medical Award”, and two skin beauty and hair experts, Dr. Zhao Zhao ming, Dr. Liu Chun xi, cosmetics law expert, Ms. Jiang attended the meeting to give a keynote speech, From the aspects of academic research, technological innovation, product application and regulations, Attracting more than 200 many domestic medical and beauty clinics and cosmetics brand related businesses to attend the meeting, Discuss the hottest topic of regenerative medical research, “Exosome” in 2023.

Source

AM Biotech and Tri-Service General Hospital discussed collaboration matters regarding preclinical research and clinical trials of biochemical pulse extracellular vesicles.

admin — Thu, 19 Jan 2023 12:54:58 +0000

AM Biotech and Tri-Service General Hospital discussed collaboration matters regarding preclinical research and clinical trials of biochemical pulse extracellular vesicles.

Source